Literature DB >> 6826026

Renal vascular effects of angiotensin II, arginine-vasopressin and bradykinin in rats: interactions with prostaglandins.

K G Hofbauer, H Dienemann, P Forgiarini, R Stalder, J M Wood.   

Abstract

1. The renal vascular responses to the peptide hormones angiotensin II (ANG II), arginine-vasopressin (AVP) and bradykinin (BK) were studied in anaesthetized rats with flow-meter techniques. The contribution of prostaglandins (PG) to their renal vascular effects was assessed with the aid of the PG-synthesis inhibitor indomethacin. 2. ANG II and AVP induced a dose-dependent increase in renal vascular resistance (RVR). The renal vasoconstrictor effects of both peptides were significantly augmented in rats pretreated with indomethacin. Indomethacin alone induced an increase in RVR, but not in mesenteric vascular resistance (MVR). 3. BK in low doses (1 micrograms/kg . min) tended to decrease RVR but increased RVR in high doses (20 micrograms/kg . min). MVR was reduced after all doses. The renal vasoconstrictor effect of BK was not affected by the ANG II-antagonist saralasin but almost completely blocked by indomethacin. 4. These results suggest that in the rat, as in other animal species and in man, renal PG's attenuate the renal effects of vasoconstrictor hormones such as ANG II and AVP. Although it has no such effect in other species. BK in high doses induces renal vasoconstriction in the rat, which appears also to be mediated by PG's. This response might be peculiar to the rat, since PG's act as renal vasodilators in other species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826026     DOI: 10.1016/0306-3623(83)90086-1

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  8 in total

1.  Regional haemodynamic effect of vasopressin infusion in conscious, unrestrained, Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

2.  The effects of infusions of arginine vasopressin or 1-deamino-8-D-arginine vasopressin on common carotid vascular resistance in conscious, Long Evans rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

3.  Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations.

Authors:  K Bagaté; L Develioglu; J L Imbs; B Michel; J J Helwig; M Barthelmebs
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

4.  Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

5.  Renal blood flow and its distribution following haemorrhage in the rat: the role of vasopressin.

Authors:  S Al-Omar Azzawi; D G Shirley
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

6.  Dose-response effects of pressor doses of arginine vasopressin on renal haemodynamics in the rat.

Authors:  A J McVicar
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

7.  Renal vasoconstriction by vasopressin V1a receptors is modulated by nitric oxide, prostanoids, and superoxide but not the ADP ribosyl cyclase CD38.

Authors:  Nicholas G Moss; Tayler E Kopple; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-12

8.  Role of Mas Receptor Antagonist A799 in Renal Blood Flow Response to Ang 1-7 after Bradykinin Administration in Ovariectomized Estradiol-Treated Rats.

Authors:  Aghdas Dehghani; Shadan Saberi; Mehdi Nematbakhsh
Journal:  Adv Pharmacol Sci       Date:  2015-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.